Gluckman P D, Leisti S, Kaplan S L, Grumbach M M
Endocrinology. 1983 May;112(5):1624-30. doi: 10.1210/endo-112-5-1624.
The administration of a dopamine antagonist, haloperidol, to the ovine fetus in late gestation elevates plasma concentrations of PRL, suggesting tonic dopaminergic inhibition of fetal PRL secretion. The source of this dopaminergic inhibition was investigated in chronically catheterized ovine fetuses (104-135 days of gestation) after hypophysial stalk section (SS; n = 4) and in sham-operated controls (CON; n = 7). Basal PRL levels were similar in the two groups of fetuses. After the administration of TRF (250 micrograms, iv), PRL levels rose comparably in both the SS and CON fetuses. The only difference was a higher mean incremental response (P less than 0.02) in the SS fetuses. The dopamine agonist apomorphine (100 micrograms/kg, iv) induced a similar suppression of fetal PRL concentrations in CON (n = 4) and SS (n = 2) fetuses. After the administration of haloperidol (1 mg, iv) to the CON fetuses (n = 7), the concentration of fetal PRL rose (P less than 0.01). In the SS fetus (n = 4), haloperidol induced a rise in PRL concentrations (P less than 0.01); however, the response to haloperidol was less (P less than 0.01) in SS than in CON fetuses. These data suggest that there is persistent dopaminergic inhibition of PRL secretion in the fetus after complete stalk section, and that the source of this dopamine is extrahypothalamic. The greater incremental PRL response to TRH and the lesser response to haloperidol in the SS fetus than in CON are evidence for a hypothalamic component to the dopaminergic inhibition in the intact fetus. Basal FSH concentrations and the gonadotropin response to LRF were not affected by stalk section in fetuses studied 5-8 days after surgery. Both the PRL and the GH responses to 5-hydroxytryptophan were abolished by stalk section. After stalk section GH levels fell, however, significant concentrations of GH were measurable in fetal plasma in late gestation, which suggests that the fetal pituitary can secrete GH in the absence of hypothalamic stimulation at this stage in gestation.
在妊娠晚期给绵羊胎儿注射多巴胺拮抗剂氟哌啶醇会提高血浆催乳素(PRL)浓度,这表明多巴胺能对胎儿PRL分泌存在紧张性抑制。在垂体柄横断(SS;n = 4)的慢性插管绵羊胎儿(妊娠104 - 135天)和假手术对照组(CON;n = 7)中研究了这种多巴胺能抑制的来源。两组胎儿的基础PRL水平相似。静脉注射促甲状腺激素释放因子(TRF,250微克)后,SS组和CON组胎儿的PRL水平均有相似程度的升高。唯一的差异是SS组胎儿的平均增量反应更高(P < 0.02)。多巴胺激动剂阿扑吗啡(100微克/千克,静脉注射)在CON组(n = 4)和SS组(n = 2)胎儿中诱导出相似的胎儿PRL浓度抑制。给CON组胎儿(n = 7)静脉注射氟哌啶醇(1毫克)后,胎儿PRL浓度升高(P < 0.01)。在SS组胎儿(n = 4)中,氟哌啶醇也诱导PRL浓度升高(P < 0.01);然而,SS组胎儿对氟哌啶醇的反应比CON组胎儿小(P < 0.01)。这些数据表明,在完全横断垂体柄后,胎儿PRL分泌仍存在持续的多巴胺能抑制,且这种多巴胺的来源是下丘脑外的。与CON组相比,SS组胎儿对促甲状腺激素释放激素(TRH)的PRL增量反应更大,对氟哌啶醇的反应更小,这证明完整胎儿中多巴胺能抑制存在下丘脑成分。在手术后5 - 8天研究的胎儿中,基础促卵泡生成素(FSH)浓度和促性腺激素对促黄体生成素释放因子(LRF)的反应不受垂体柄横断的影响。垂体柄横断后,PRL和生长激素(GH)对5 - 羟色氨酸的反应均消失。然而,垂体柄横断后GH水平下降,但在妊娠晚期胎儿血浆中仍可检测到显著浓度的GH,这表明在此妊娠阶段,胎儿垂体在没有下丘脑刺激的情况下也能分泌GH。